High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
@article{Lee2007HighresolutionDH,
title={High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.},
author={Stephanie J. Lee and John P. Klein and Michael D. Haagenson and Lee Ann Baxter‐Lowe and Dennis L. Confer and Mary Eapen and Marcelo A. Fernandez-Vina and Neal Flomenberg and Mary M Horowitz and Carolyn Katovich Hurley and Harriet J. Noreen and Machteld Oudshoorn and Effie W. Petersdorf and Michelle I Setterholm and Stephen R. Spellman and Daniel J. Weisdorf and Thomas M. Williams and Claudio M. Anasetti},
journal={Blood},
year={2007},
volume={110 13},
pages={
4576-83
}
}The relative importance of various human leukocyte antigen (HLA) loci and the resolution level at which they are matched has not been fully defined for unrelated donor transplantation. To address this question, National Marrow Donor Program data from 3857 transplantations performed from 1988 to 2003 in the United States were analyzed. Patient-donor pairs were fully typed for HLA-A, -B, -C, -DRB1, -DQB1, -DQA1, -DPB1, and -DPA1 alleles. High-resolution DNA matching for HLA-A, -B, -C, and -DRB1…
1,071 Citations
HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
- Medicine, BiologyBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- 2011
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.
- Medicine, BiologyBlood
- 2012
Patients with NMD should receive transplants from allele matched (8/8) donors if possible, and HLA mismatches in NMD is associated with graft failure rather than GVHD.
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants
- Medicine, BiologyBone Marrow Transplantation
- 2017
It is suggested that HLA and CMV matching status should be considered when selecting unrelated donors and thatCMV matching may abrogate the effect of an HLA mismatch.
How to select the best available related or unrelated donor of hematopoietic stem cells?
- Biology, MedicineHaematologica
- 2016
Genetic factors that help in identifying donors with less immunogenic mismatches are discussed, and HLA typing by next-generation sequencing methods is likely to change matching algorithms by providing full sequence information on all HLA loci in a single step.
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
- Biology, MedicineBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- 2008
Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.
- Biology, MedicineHematology. American Society of Hematology. Education Program
- 2019
Functional HLA matching might prove to have increasing importance for URD selection in the era of new immunosuppressive regimens that have the potential to substantially reshuffle the role of HLA mismatches in URD HCT.
Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
- Biology, MedicineBlood
- 2015
The biological response to HLA locus mismatch in transplant-related immunologic events is determined, and a rationale for use of a personalized algorithm for unrelated donor selection is provided.
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
- Medicine, BiologyBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- 2019
The Impact of HLA-C Matching on Donor Identification Rates in a European-Caucasian Population
- BiologyFront. Immunol.
- 2014
The impact of adding HLA-C at low or high resolution as a supplementary matching criterion on some key parameters in donor provision for a European-Caucasian population is investigated and contributes to quantifying the medical and economic impact of the progress in donor selection algorithms.
Impact of highly conserved HLA haplotype on acute graft-versus-host disease.
- Biology, MedicineBlood
- 2010
This study is the first to demonstrate that a genetic difference derived from HLA haplotype itself is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation.
References
SHOWING 1-10 OF 27 REFERENCES
Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
- Medicine, BiologyBlood
- 2004
A single HLA allele or antigen mismatch was associated with increased mortality among patients with chronic myeloid leukemia within 2 years after diagnosis compared to patients with no HLA mismatch, but not among those with more advanced malignancy.
The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
- Medicine, BiologyBlood
- 1995
Molecular typing of DRB1 alleles can allow more accurate donor/recipient matching and thereby improve clinical outcome after marrow transplantation and results indicate that prospective matching of patients and donors for DRB 1 alleles is warranted.
Isolated HLA-C mismatches in unrelated donor transplantation for CML
- Medicine, BiologyBone Marrow Transplantation
- 2004
In spite of their lower expression, HLA-C antigens still represent relevant transplantation barriers that should be considered when searching for an unrelated donor.
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
- MedicineBlood
- 2004
It is concluded that matching for HLA-C should be incorporated into algorithms for unrelated donor selection, and when clinical circumstances allow, high-resolution class I typing may help optimize donor selection and improve outcome.
Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
- Medicine, BiologyThe New England journal of medicine
- 1998
Genomic typing of class I HLA alleles adds substantially to the success of transplantation of hematopoietic stem cells from unrelated donors, even if the donors are serologically identical to their recipients with respect to HLA-A, B, and DR antigens.
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
- Biology, MedicineBlood
- 2001
A good-risk population of patients whose transplantations were performed in the first CP of disease from HLA-A, B, DRB1 matched unrelated donors can be shown to have superior survival.
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism.
- Biology, MedicineBlood
- 2007
Evidence is provided to elucidate the mechanism of aGVHD on the basis of HLA molecule and the identification of high-risk mismatch, that is, nonpermissive mismatch, would be beneficial for the selection of a suitable donor.
MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation
- Medicine, BiologyPLoS medicine
- 2007
The phasing method provides an approach for mapping novel MHC-linked transplantation determinants and a means to decrease GVHD-related morbidity after HCT from unrelated donors.
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
- Biology, MedicineBlood
- 2002
The role of the HLA class I allele in unrelated bone marrow transplantation was elucidated, and Notably, HLA-C alleles had a different mode from Hla-A or -B alleles for acute GVHD and survival.
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
- Medicine, BiologyBlood
- 1993
The results indicate that matching patients and unrelated donors for HLA-A, -B, -DRB, and -DQB does not predict for matching at DPB1, However, recipient incompatibility for DPB 1 alleles does not detectably influence the risk of acute GVHD and should not be used as an exclusion criterion for donor selection in unrelated marrow transplantation.






